Lukas Prantl

Prof. Dr. Lukas Prantl

President of the German Society for Plastic, Reconstructive and Aesthetic Surgery (DGPRÄC)
+1
orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in AIAA Journal
Verified
Journal Article
Closed access
NTNils Thuerey
Nils Thuerey
KWKonstantin Weißenow
Konstantin Weißenow
Lukas PrantlLukas Prantl
Lukas Prantl
XHXiangyu Hu
Xiangyu Hu
This study investigates the accuracy of deep learning models for the inference of Reynolds-averaged Navier–Stokes (RANS) solutions. This study focuses on a modernized U-net architecture and evaluat...

15 April 2010 in British Journal of Dermatology
Verified
Journal Article
Closed access
SSStephan Schreml
Stephan Schreml
RSR.M. Szeimies
R.M. Szeimies
Lukas PrantlLukas Prantl
Lukas Prantl
SKS. Karrer
S. Karrer
MLM. Landthaler
M. Landthaler
PBP. Babilas
P. Babilas

20 April 2010 in Cells Tissues Organs
Verified
Journal Article
Closed access
PDF file
MMMichael B. Mueller
Michael B. Mueller
MFMaria Fischer
Maria Fischer
JZJohannes Zellner
Johannes Zellner
ABArne Berner
Arne Berner
TDThomas Dienstknecht
Thomas Dienstknecht
PAPeter Angele
Peter Angele
Induction of chondrogenesis in mesenchymal stem cells (MSCs) with TGF-β leads to a hypertrophic phenotype. The hypertrophic maturation of the chondrocytes is dependent on the timed removal of TGF-β and sensitive to hypertrophy-promoting agents in vitro. In this study, we have investigated whether TGF-β3, which has been shown to be more prochondrogenic compared to TGF-β1, similarly enhances terminal differentiation in an in vitro hypertrophy model of chondrogenically differentiating MSCs. In addition, we tested the impact of the time of chondrogenic conditioning on the enhancement of hypertrophy. MSCs were chondrogenically differentiated in pellet culture in medium containing TGF-β1 or TGF-β3. After 2 or 4 weeks, chondrogenic medium was switched to hypertrophy-inducing medium for 2 weeks. Aggregates were analyzed histologically and biochemically on days 14, 28 and 42. The switch to hypertrophy medium after 14 days induced hypertrophic cell morphology and significant increase in alkaline phosphatase activity compared to the chondrogenesis only control using both TGF-β1 and TGF-β3. After 28 days predifferentiation, differences between hypertrophic and control groups diminished compared to 14 days predifferentiation. In conclusion, chondrogenic conditioning with both TGF-β isoforms similarly induced hypertrophy in our experiment and allowed the enhancement of the hypertrophic chondrocyte phenotype by hypertrophic medium. Enhancement of hypertrophy was seen more clearly after the shorter chondrogenic conditioning. Therefore, to utilize this experimental model as a tool to study hypertrophy in MSC chondrogenesis, a predifferentiation period of 14 days is recommended.

1 June 2020 in Deutsches Ärzteblatt international
Verified
Journal Article
Closed access
PKPhilipp Kruppa
Philipp Kruppa
IGIakovos Georgiou
Iakovos Georgiou
NBNiklas Biermann
Niklas Biermann
Lukas PrantlLukas Prantl
Lukas Prantl
PKPeter Klein-Weigel
Peter Klein-Weigel
MGMojtaba Ghods
Mojtaba Ghods
Lipedema is often unrecognized or misdiagnosed; despite an estimated prevalence of 10% in the overall female population, its cause is still unknown. There is increasing awareness of this condition, but its differential diagnosis can still be challenging. In this article, we summarize current hypotheses on its pathogenesis and the recommendations of current guidelines for its diagnosis and treatment. This review is based on publications about lipedema that were retrieved by a selective search in the MEDLINE, Web of Science, and Cochrane Library databases. The pathophysiology of lipedema remains unclear. The putative causes that have been proposed include altered adipogenesis, microangiopathy, and disturbed lymphatic microcirculation. No specific biomarker has yet been found, and the diagnosis is currently made on clinical grounds alone. Ancillary tests are used only to rule out competing diagnoses. The state of the evidence on treatment is poor. Treatment generally consists of complex decongestive therapy. In observational studies, liposuction for the permanent reduction of adipose tissue has been found to relieve symptoms to a significant extent, with only rare complications. The statutory health-insurance carriers in Germany do not yet regularly cover the cost of the procedure; studies of high methodological quality will be needed before this is the case. The diagnosis of lipedema remains a challenge because of the heterogeneous presentation of the condition and the current lack of objective measuring instruments to characterize it. This review provides a guide to its diagnosis and treatment in an interdisciplinary setting. Research in this area should focus on the elucidation of the pathophysiology of lipedema and the development of a specific biomarker for it.

1 April 2021 in Immunity
Verified
Journal Article
Open access
MDMichael Delacher
Michael Delacher
MSMalte Simon
Malte Simon
LSLieke Sanderink
Lieke Sanderink
AHAgnes Hotz-Wagenblatt
Agnes Hotz-Wagenblatt
MWMarina Wuttke
Marina Wuttke
MFMarkus Feuerer
Markus Feuerer
Murine regulatory T (Treg) cells in tissues promote tissue homeostasis and regeneration. We sought to identify features that characterize human Treg cells with these functions in healthy tissues. Single-cell chromatin accessibility profiles of murine and human tissue Treg cells defined a conserved, microbiota-independent tissue-repair Treg signature with a prevailing footprint of the transcription factor BATF. This signature, combined with gene expression profiling and TCR fate mapping, identified a population of tissue-like Treg cells in human peripheral blood that expressed BATF, chemokine receptor CCR8 and HLA-DR. Human BATF+CCR8+ Treg cells from normal skin and adipose tissue shared features with nonlymphoid T follicular helper-like (Tfh-like) cells, and induction of a Tfh-like differentiation program in naive human Treg cells partially recapitulated tissue Treg regenerative characteristics, including wound healing potential. Human BATF+CCR8+ Treg cells from healthy tissue share features with tumor-resident Treg cells, highlighting the importance of understanding the context-specific functions of these cells.

Verified
Journal Article
Open access
PDF file
BKBritta Kuehlmann
Britta Kuehlmann
CBClark A. Bonham
Clark A. Bonham
IZIsabel Zucal
Isabel Zucal
Lukas PrantlLukas Prantl
Lukas Prantl
GGGeoffrey C. Gurtner
Geoffrey C. Gurtner
Skin injury is a common occurrence and mechanical forces are known to significantly impact the biological processes of skin regeneration and wound healing. Immediately following the disruption of the skin, the process of wound healing begins, bringing together numerous cell types to collaborate in several sequential phases. These cells produce a multitude of molecules and initiate multiple signaling pathways that are associated with skin disorders and abnormal wound healing, including hypertrophic scars, keloids, and chronic wounds. Studies have shown that mechanical forces can alter the microenvironment of a healing wound, causing changes in cellular function, motility, and signaling. A better understanding of the mechanobiology of cells in the skin is essential in the development of efficacious therapeutics to reduce skin disorders, normalize abnormal wound healing, and minimize scar formation.